Literature DB >> 12796264

Does benzalkonium chloride cause cataract?

James D Brandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12796264     DOI： 10.1001/archopht.121.6.892

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

Review 1.  Evolving paradigms in the medical treatment of glaucoma.

Authors:  John S Cohen; Anup K Khatana; Linda J Greff
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

2.  Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies.

Authors:  Kai Kaarniranta; Kirsi Ikäheimo; Eliisa Mannermaa; Auli Ropo
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

3.  In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).

Authors:  Christophe Baudouin; Alexandre Denoyer; Nicolas Desbenoit; Gregory Hamm; Alice Grise
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

4.  Lens epithelial cell death secondary to acanthamoeba keratitis: absence of capsular bag opacification six years after cataract surgery.

Authors:  Javier Moreno-Montañés; Jesús Barrio-Barrio; Elisa De-Nova; Liliana Werner
Journal:  Case Rep Ophthalmol       Date:  2011-12-02

5.  Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study.

Authors:  Yoshihiko Esaki; Atsushi Shimazaki; Pertti Pellinen
Journal:  Open Ophthalmol J       Date:  2016-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.